"Das Brust-Zentrum ist ein Team von Gynäkologen, Chirurgen, Onkologen, Radiologen und plastischen Chirurgen, ergänzt durch weitere Fachspezialisten wie Ärztinnen für die genetische Beratung oder die Komplementärmedizin, eine Psychoonkologin und eine Sexualtherapeutin, deren Ziel es ist, für ihre Patientinnen und Patienten eine ganzheitliche Betreuung, Beratung, Begleitung und medizinische Versorgung bei Brusterkrankungen anzubieten. Unterstützt werden sie dabei durch unsere Studienabteilung, die Breast-Care-Nurses, die onkologischen Pflegefachfrauen, die medizinischen Praxisassistentinnen und die medizinisch-technischen Radiologieassistentinnen. Unsere/r Patient/in steht im Zentrum. Wir bieten eine optimale Betreuung unter einem Dach."

During the past decade, Brust-Zentrum Zurich conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 5 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brust-Zentrum Zurich" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Swiss Group for Clinical Cancer Research" with 5 trials sponsored, "ETOP IBCSG Partners Foundation" with 3 trials sponsored, "Brust-Zentrum AG" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brust-Zentrum Zurich" #1 collaborator was "Breast International Group" with 6 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 4 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Brust-Zentrum Zurich" are "Breast Cancer" (11 trials), "Triple Negative Breast Cancer" (4 trials), "Early Breast Cancer" (3 trials), "Adenocarcinoma" (1 trials) and "Bone Metastases" (1 trials). Many other conditions were trialed in "Brust-Zentrum Zurich" in a lesser frequency.

Most popular intervention types in "Brust-Zentrum Zurich" are "Drug" (15 trials), "Procedure" (4 trials), "Radiation" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Carboplatin" (4 trials), "Cyclophosphamide" (3 trials), "5-Fluorouracil" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Brust-Zentrum Zurich" are 14 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Brust-Zentrum Zurich". undefined are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Brust-Zentrum Zurich, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Brust-Zentrum Zurich, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".